logo
Sign In
  1. Home
  2. Indications
  3. Anemia Irondeficiency

Medications for Anemia Irondeficiency

FiltersReset Filters
9 results

  • deferasirox

    (Deferasirox)
    Medication Details
    Teva Pharmaceuticals Inc
    Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.
    Medication Details
    Drug Interactions

  • deferasirox

    (deferasirox)
    Medication Details
    Bionpharma Inc.
    Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for patients aged 10 and older with non-transfusion-dependent thalassemia syndromes who have specific liver iron levels and serum ferritin. Its safety with other iron chelation therapies is not established.
    Medication Details
    Drug Interactions

  • deferasirox

    (Deferasirox)
    Medication Details
    Ascend Laboratories, LLC
    Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.
    Medication Details
    Drug Interactions

  • deferasirox

    (Deferasirox)
    Medication Details
    Actavis Pharma, Inc.
    Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron and serum ferritin levels.
    Medication Details
    Drug Interactions

  • deferasirox oral granules

    (deferasirox)
    Medication Details
    EPIC PHARMA, LLC
    Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 years and older with specific iron levels.
    Medication Details
    Drug Interactions

  • deferasorox

    (Deferasirox)
    Medication Details
    MSN LABORATORIES PRIVATE LIMITED
    Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration criteria. Safety with other iron chelation therapies is not established.
    Medication Details
    Drug Interactions

  • deferasorox

    (Deferasirox)
    Medication Details
    Novadoz Pharmaceuticals LLC
    Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, as well as for those aged 10 and older with non-transfusion dependent thalassemia syndromes, if specific liver iron concentration and serum ferritin levels are met.
    Medication Details
    Drug Interactions

  • ferric citrate

    (Ferric Citrate)
    Medication Details
    Mylan Pharmaceuticals Inc.
    Usage: Ferric citrate tablets are indicated for controlling serum phosphorus levels in adults with chronic kidney disease on dialysis, and for treating iron deficiency anemia in adults with chronic kidney disease not on dialysis.
    Medication Details
    Drug Interactions

  • sodium ferric gluconate complex in sucrose

    (Sodium Ferric Gluconate Complex in Sucrose)
    Medication Details
    Hikma Pharmaceuticals USA Inc.
    Usage: Sodium ferric gluconate complex in sucrose injection is indicated for treating iron deficiency anemia in adults and pediatric patients aged 6 years and older with chronic kidney disease on hemodialysis receiving supplemental epoetin therapy.
    Medication Details
    Drug Interactions
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.